The AMIDEX Cancer Innovations & Healthcare Mutual Fund Performance













The AMIDEX Cancer Innovation & Healthcare Mutual Fund is not diversified and is composed of only 45 companies. All investments are inherently subject to market risk. The relatively limited liquidity of some of the equities in the portfolio may affect the fund's ability to acquire desired positions quickly or unable to dispose of securities at a desirable price and time.

An investor's return and principal value will fluctuate so that an investor's shares, when redeemed, may be more or less than their original cost. For a complete discussion of the risks, charges and expenses please call1-888-876-3566. Please read the prospectus carefully before you invest or send money. InCap Securities, Willow Grove, PA 19428 distributes the Fund.